 In January 2019, during the 2018–19 United States federal government shutdown, Gillibrand was one of thirty-four senators to sign a letter to Commissioner of Food and Drugs Scott Gottlieb recognizing the efforts of the FDA to address the effect of the government shutdown on the public health and employees while remaining alarmed "that the continued shutdown will result in increasingly harmful effects on the agency’s employees and the safety and security of the nation’s food and medical products.